Drug Type Small molecule drug |
Synonyms BBI 5000 |
Target |
Action antagonists |
Mechanism CRTH2 antagonists(Prostaglandin D2 receptor 2 antagonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Dermatitis, Atopic | Phase 1 | United States | 01 Oct 2015 |





